Trial Profile

A study of combination of INCB99280 and RP1 in patients with cutaneous squamous cell carcinoma

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 03 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

03 Aug 2023 New trial record
31 Jul 2023 According to a Replimune media release, the company has entered into a clinical trial collaboration and supply agreement with Incyte to study RP1 and INCB99280 combination in patients with Cutaneous Squamous Cell Carcinoma. Under the terms of the agreement, Incyte will initiate and sponsor the clinical trial with the clinical trial expected to initiate in early 2024. Replimune will supply Incyte with RP1 for the study and share equally in the costs of the study.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com